Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Yorkshire Concept Board Meeting, March 2010

The latest approved projects are:

Recombinant Protein Expression Enhancer

 

Biopharmaceuticals are recombinant proteins made from genetically engineered bacteria or mammalian cells and generate a global market of$50 billion pa. Their large-scale production is expensive - particularly for mammalian cells. Our technology is a Recombinant Protein Expression Enhancer which boosts production of recombinant proteins by mammalian cells by a remarkable 400-500%; this could dramatically reduce production costs in the biotechnology industry. Proposal sponsored by the University of Sheffield and approved at the March 2009 Yorkshire Fund Board meeting.

News

designed by
Registered Office Sheffield, S1 1WB